Medical Marijuana, Inc. Subsidiary HempMeds® Announces Distribution Partnership with Shopaholic Boutique, Inc. and 38 Other Retailers

SAN DIEGO, Feb. 21, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary HempMeds® announced today that in January 2019 the company secured a partnership with major retailer Shopaholic Boutique, Inc. and 38 other retailers to sell its hemp cannabidiol (CBD) products. The company is excited to develop long lasting strategic partnerships with these retail locations.

“We are proud of our January results and could not be more excited about the number of retail locations added to our network,” said HempMeds® President Todd Morrow. “Our brick-and-mortar store presence is a strategic imperative for our business in 2019 and we plan to announce several new and exciting products that will further our growth significantly.”

Shopaholic Boutique, Inc. has three retail locations in St. Augustine, Fla., and is the area’s leading clothing boutique serving St. Johns county and surrounding areas since 2006. They offer women’s apparel, dresses, blouses, pants, accessories, jewelry and now, for the first-time, CBD products.

“It’s an honor to work with HempMeds and its long-running history success in the CBD industry,” said Morris Mezin, Owner of Shopaholic Boutique, Inc. “We feel confident that this company will help us provide the quality and consistency our customers expect and their products will give us the opportunity to capture a new audience.”

“Our subsidiary HempMeds is making great progress thus far in 2019,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We foresee the company to continue on this path of upward mobility and continue to increase access to CBD products throughout the U.S.”

For more information on HempMeds®, please visit

About HempMeds®

HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC:MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

P. 858-264-6600

[email protected]